Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses: A randomized clinical trial

Tatyana A. Petukhova, Lauren A. Hassoun, Negar Foolad, Mayanka Barath, Raja K Sivamani

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

IMPORTANCE Photodynamic therapy (PDT) is an effective and cosmetically favorable treatment modality for actinic keratoses (AKs). However, prolonged incubation times and pain associated with treatment are burdensome to the patient and a hindrance to widespread use of PDT as standard field therapy for AK. OBJECTIVE To evaluate efficacy and pain associated with microneedle expedited PDT. DESIGN, SETTING, AND PARTICIPANTS The Microneedle Photodynamic Therapy II (MNPDT-II) study was a randomized, single-blinded, split-face controlled, 2-arm clinical trial. Thirty-three participants with AK on the face were recruited in a university dermatology outpatient clinic from 2015 to 2016, and 32 participants completed the study. INTERVENTIONS Participants were randomized into 2 incubations arms, either 10-minute or 20-minute aminolevulinic acid (ALA) incubation times, after pretreatment with a microneedle roller (200 um) vs a sham roller. They were blinded to the laterality of microneedle and sham roller assignments. After incubation, they were exposed to blue light (Blu-U, Dusa Pharmaceuticals) for 1000 seconds for a total fluence of 10 J/cm2. MAIN OUTCOMES AND MEASURES The primary outcomewas to quantitatively measure AK resolution, and the secondary outcome was to assess pain associated with microneedle pretreatment. RESULTS Thirty-three individuals were recruited and randomized to either the 20-minute or the 10-minute incubation arm. Thirty-two participants completed the study with a mean follow-up time of 34.5 days in the 20-minute group, and 30.2 days in the 10-minute group. For the 20-minute incubation arm, average AK clearance was 76%vs 58%on the sham side (P < .01), including 3 patients with complete clearance, although not statistically significant (P = .25). Pain assessment on the visual analog scale (VAS) during blue light illumination was not significantly different between the microneedle and sham sides (0.7 and 0.4; P = .28), respectively. For the 10-minute incubation arm AK clearance for the microneedle pretreated side was 43%compared with 38%on the sham side (P = .66). Pain during the blue light exposure was not significantly different between the microneedle and sham sides, 4.5mm and 3.4mm (P = .21), respectively. CONCLUSIONS AND RELEVANCE Photodynamic therapy with microneedle pretreatment at a 20-minute ALA incubation time significantly improved AK clearance with efficacy similar to that of a conventional 1-hour ALA incubation time. The additional advantage to expedited treatment was that the procedure was virtually painless. However, expedited exposure of a 10-minute ALA incubation time did not reach significantly different AK clearance from the sham control.

Original languageEnglish (US)
Pages (from-to)637-643
Number of pages7
JournalJAMA Dermatology
Volume153
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

Actinic Keratosis
Photochemotherapy
Randomized Controlled Trials
Aminolevulinic Acid
Arm
Pain
Therapeutics
Light
Pain Measurement
Dermatology
Ambulatory Care Facilities
Lighting
Visual Analog Scale
Clinical Trials

ASJC Scopus subject areas

  • Dermatology

Cite this

Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses : A randomized clinical trial. / Petukhova, Tatyana A.; Hassoun, Lauren A.; Foolad, Negar; Barath, Mayanka; Sivamani, Raja K.

In: JAMA Dermatology, Vol. 153, No. 7, 01.07.2017, p. 637-643.

Research output: Contribution to journalArticle

Petukhova, Tatyana A. ; Hassoun, Lauren A. ; Foolad, Negar ; Barath, Mayanka ; Sivamani, Raja K. / Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses : A randomized clinical trial. In: JAMA Dermatology. 2017 ; Vol. 153, No. 7. pp. 637-643.
@article{3c1fc97c8851469c962c8d520f0f5ca1,
title = "Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses: A randomized clinical trial",
abstract = "IMPORTANCE Photodynamic therapy (PDT) is an effective and cosmetically favorable treatment modality for actinic keratoses (AKs). However, prolonged incubation times and pain associated with treatment are burdensome to the patient and a hindrance to widespread use of PDT as standard field therapy for AK. OBJECTIVE To evaluate efficacy and pain associated with microneedle expedited PDT. DESIGN, SETTING, AND PARTICIPANTS The Microneedle Photodynamic Therapy II (MNPDT-II) study was a randomized, single-blinded, split-face controlled, 2-arm clinical trial. Thirty-three participants with AK on the face were recruited in a university dermatology outpatient clinic from 2015 to 2016, and 32 participants completed the study. INTERVENTIONS Participants were randomized into 2 incubations arms, either 10-minute or 20-minute aminolevulinic acid (ALA) incubation times, after pretreatment with a microneedle roller (200 um) vs a sham roller. They were blinded to the laterality of microneedle and sham roller assignments. After incubation, they were exposed to blue light (Blu-U, Dusa Pharmaceuticals) for 1000 seconds for a total fluence of 10 J/cm2. MAIN OUTCOMES AND MEASURES The primary outcomewas to quantitatively measure AK resolution, and the secondary outcome was to assess pain associated with microneedle pretreatment. RESULTS Thirty-three individuals were recruited and randomized to either the 20-minute or the 10-minute incubation arm. Thirty-two participants completed the study with a mean follow-up time of 34.5 days in the 20-minute group, and 30.2 days in the 10-minute group. For the 20-minute incubation arm, average AK clearance was 76{\%}vs 58{\%}on the sham side (P < .01), including 3 patients with complete clearance, although not statistically significant (P = .25). Pain assessment on the visual analog scale (VAS) during blue light illumination was not significantly different between the microneedle and sham sides (0.7 and 0.4; P = .28), respectively. For the 10-minute incubation arm AK clearance for the microneedle pretreated side was 43{\%}compared with 38{\%}on the sham side (P = .66). Pain during the blue light exposure was not significantly different between the microneedle and sham sides, 4.5mm and 3.4mm (P = .21), respectively. CONCLUSIONS AND RELEVANCE Photodynamic therapy with microneedle pretreatment at a 20-minute ALA incubation time significantly improved AK clearance with efficacy similar to that of a conventional 1-hour ALA incubation time. The additional advantage to expedited treatment was that the procedure was virtually painless. However, expedited exposure of a 10-minute ALA incubation time did not reach significantly different AK clearance from the sham control.",
author = "Petukhova, {Tatyana A.} and Hassoun, {Lauren A.} and Negar Foolad and Mayanka Barath and Sivamani, {Raja K}",
year = "2017",
month = "7",
day = "1",
doi = "10.1001/jamadermatol.2017.0849",
language = "English (US)",
volume = "153",
pages = "637--643",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Effect of expedited microneedle-assisted photodynamic therapy for field treatment of actinic keratoses

T2 - A randomized clinical trial

AU - Petukhova, Tatyana A.

AU - Hassoun, Lauren A.

AU - Foolad, Negar

AU - Barath, Mayanka

AU - Sivamani, Raja K

PY - 2017/7/1

Y1 - 2017/7/1

N2 - IMPORTANCE Photodynamic therapy (PDT) is an effective and cosmetically favorable treatment modality for actinic keratoses (AKs). However, prolonged incubation times and pain associated with treatment are burdensome to the patient and a hindrance to widespread use of PDT as standard field therapy for AK. OBJECTIVE To evaluate efficacy and pain associated with microneedle expedited PDT. DESIGN, SETTING, AND PARTICIPANTS The Microneedle Photodynamic Therapy II (MNPDT-II) study was a randomized, single-blinded, split-face controlled, 2-arm clinical trial. Thirty-three participants with AK on the face were recruited in a university dermatology outpatient clinic from 2015 to 2016, and 32 participants completed the study. INTERVENTIONS Participants were randomized into 2 incubations arms, either 10-minute or 20-minute aminolevulinic acid (ALA) incubation times, after pretreatment with a microneedle roller (200 um) vs a sham roller. They were blinded to the laterality of microneedle and sham roller assignments. After incubation, they were exposed to blue light (Blu-U, Dusa Pharmaceuticals) for 1000 seconds for a total fluence of 10 J/cm2. MAIN OUTCOMES AND MEASURES The primary outcomewas to quantitatively measure AK resolution, and the secondary outcome was to assess pain associated with microneedle pretreatment. RESULTS Thirty-three individuals were recruited and randomized to either the 20-minute or the 10-minute incubation arm. Thirty-two participants completed the study with a mean follow-up time of 34.5 days in the 20-minute group, and 30.2 days in the 10-minute group. For the 20-minute incubation arm, average AK clearance was 76%vs 58%on the sham side (P < .01), including 3 patients with complete clearance, although not statistically significant (P = .25). Pain assessment on the visual analog scale (VAS) during blue light illumination was not significantly different between the microneedle and sham sides (0.7 and 0.4; P = .28), respectively. For the 10-minute incubation arm AK clearance for the microneedle pretreated side was 43%compared with 38%on the sham side (P = .66). Pain during the blue light exposure was not significantly different between the microneedle and sham sides, 4.5mm and 3.4mm (P = .21), respectively. CONCLUSIONS AND RELEVANCE Photodynamic therapy with microneedle pretreatment at a 20-minute ALA incubation time significantly improved AK clearance with efficacy similar to that of a conventional 1-hour ALA incubation time. The additional advantage to expedited treatment was that the procedure was virtually painless. However, expedited exposure of a 10-minute ALA incubation time did not reach significantly different AK clearance from the sham control.

AB - IMPORTANCE Photodynamic therapy (PDT) is an effective and cosmetically favorable treatment modality for actinic keratoses (AKs). However, prolonged incubation times and pain associated with treatment are burdensome to the patient and a hindrance to widespread use of PDT as standard field therapy for AK. OBJECTIVE To evaluate efficacy and pain associated with microneedle expedited PDT. DESIGN, SETTING, AND PARTICIPANTS The Microneedle Photodynamic Therapy II (MNPDT-II) study was a randomized, single-blinded, split-face controlled, 2-arm clinical trial. Thirty-three participants with AK on the face were recruited in a university dermatology outpatient clinic from 2015 to 2016, and 32 participants completed the study. INTERVENTIONS Participants were randomized into 2 incubations arms, either 10-minute or 20-minute aminolevulinic acid (ALA) incubation times, after pretreatment with a microneedle roller (200 um) vs a sham roller. They were blinded to the laterality of microneedle and sham roller assignments. After incubation, they were exposed to blue light (Blu-U, Dusa Pharmaceuticals) for 1000 seconds for a total fluence of 10 J/cm2. MAIN OUTCOMES AND MEASURES The primary outcomewas to quantitatively measure AK resolution, and the secondary outcome was to assess pain associated with microneedle pretreatment. RESULTS Thirty-three individuals were recruited and randomized to either the 20-minute or the 10-minute incubation arm. Thirty-two participants completed the study with a mean follow-up time of 34.5 days in the 20-minute group, and 30.2 days in the 10-minute group. For the 20-minute incubation arm, average AK clearance was 76%vs 58%on the sham side (P < .01), including 3 patients with complete clearance, although not statistically significant (P = .25). Pain assessment on the visual analog scale (VAS) during blue light illumination was not significantly different between the microneedle and sham sides (0.7 and 0.4; P = .28), respectively. For the 10-minute incubation arm AK clearance for the microneedle pretreated side was 43%compared with 38%on the sham side (P = .66). Pain during the blue light exposure was not significantly different between the microneedle and sham sides, 4.5mm and 3.4mm (P = .21), respectively. CONCLUSIONS AND RELEVANCE Photodynamic therapy with microneedle pretreatment at a 20-minute ALA incubation time significantly improved AK clearance with efficacy similar to that of a conventional 1-hour ALA incubation time. The additional advantage to expedited treatment was that the procedure was virtually painless. However, expedited exposure of a 10-minute ALA incubation time did not reach significantly different AK clearance from the sham control.

UR - http://www.scopus.com/inward/record.url?scp=85024130355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024130355&partnerID=8YFLogxK

U2 - 10.1001/jamadermatol.2017.0849

DO - 10.1001/jamadermatol.2017.0849

M3 - Article

C2 - 28514458

AN - SCOPUS:85024130355

VL - 153

SP - 637

EP - 643

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 7

ER -